Clinical trials
Observational trials in North Macedonia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 5 |
| Unknown status | 5 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 6 |
| Hoffmann-La Roche | 6 |
| Novo Nordisk A/S | 4 |
| Terumo Europe N.V. | 2 |
| CENTOGENE GmbH Rostock | 1 |
| Cardiovascular and Interventional Radiological Society of Europe | 1 |
| European Association of Urology Research Foundation | 1 |
| European Cardiovascular Research Center | 1 |
| Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 1 |
| Genzyme, a Sanofi Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 4 |
| Diabetes Mellitus | 3 |
| Heart Failure | 3 |
| Hepatitis C, Chronic | 3 |
| Angioedemas, Hereditary | 2 |
| Breast Neoplasms | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Venous Thromboembolism | 2 |
| Acute Kidney Injury | 1 |
| Amyloid Neuropathies | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.